Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure

Clinical trial NCT04278092 · COMPLETED

Trial details

NCT number: NCT04278092
Sponsor: Medical University of Vienna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2020-02-10
Primary completion: 2024-10-31
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.